reSee.it - Related Video Feed

The speaker's administration will implement "most favored nations" drug pricing, ensuring Americans pay the lowest price for drugs compared to other developed countries. Some prescription drug prices will be reduced almost immediately by 50% to 90%. Big Pharma must voluntarily comply or the federal government will ensure equal pricing. To accelerate price reductions, the administration will cut out the middlemen to facilitate direct drug sales to American citizens at the most favored nation price. The speaker believes the middlemen are worse than drug companies because they don't make a product but make a fortune.

The speaker claims the United States spends $1,126 per capita on drugs, while Britain spends about $240, approximately one-fifth of the U.S. figure, a trend seen across Europe. The speaker says drug companies claim America must pay for pharmaceutical innovation. President Trump is quoted as saying European partners need to increase their drug payments to cover their share of innovation, asserting the U.S. should no longer subsidize it. The speaker concludes that if Europeans raised drug prices by 20%, the resulting $10 trillion could be spent on innovation, improving global health.

There are 1,800 big pharma lobbyists in Washington, influencing policies significantly. This raises concerns about their impact on public health and safety. To combat this, one solution is to prohibit government officials from becoming lobbyists after their term. Currently, there are regulations that limit this, but they often allow for loopholes, enabling former officials to work for companies they once regulated. This creates conflicts of interest, as seen with the Sackler family and the FDA. While addressing these issues is crucial, it often gets sidelined by other pressing matters.

Over 100 members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its European manufacturer. Once Medicare approves it, Medicaid follows. There's a push to prescribe Ozempic to kids as young as six for obesity, a largely preventable condition. With 74% of Americans obese, covering everyone's Ozempic would cost $3 trillion annually. Ozempic has made Novo Nordisk Europe's largest company, yet Denmark recommends diet and exercise instead. The company's value relies heavily on projected Ozempic sales in the US. For half the cost, we could provide organic food and gym memberships for every obese American. Why are politicians siding with a Danish company over American farmers and kids? Because Novo Nordisk heavily funds medical research, influencing media, politicians, and medical schools.

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world. They claim drug companies have tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. Despite this, the speaker says they don't care and must do what's right.

Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. This drug, aimed at treating obesity—a largely preventable condition—could cost the U.S. $3 trillion annually if prescribed widely, as 74% of Americans are obese. While Novo Nordisk thrives, the Danish government promotes diet and exercise instead. For half the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk extends to medical research funding, leading to complicity from media, politicians, and medical schools.

Former President Trump claims that he was the only president to take on big pharma, but Joe Biden canceled his toughened pharmaceutical policies. Trump signed an executive order to ensure that the US government pays the same price for pharmaceuticals as other countries, saving American patients billions of dollars. However, Biden reversed this order, allowing other countries to negotiate lower prices while Americans pay high prices. Trump promises that if he is reelected, he will sign an executive order to end this unfair practice and make Big Pharma lower prices for American patients. He believes that rescinding his original order shows the power of Big Pharma, but he is determined to deliver savings for seniors and all American patients.

The administration will secure "most favored nations" drug pricing, meaning Americans will pay the lowest price for drugs paid in other developed countries. Some prescription drug prices will be reduced almost immediately by 50 to 90%. Big Pharma will either abide by this principle voluntarily, or the federal government will ensure Americans pay the same price as other countries. To accelerate price reductions, the administration will cut out the middlemen and facilitate the direct sale of drugs at the most favored nation price directly to American citizens. The middlemen are considered worse than the drug companies because they don't make a product but make a fortune.

Robert F. Kennedy Jr. praises President Trump for addressing the discrepancy between US and European drug prices, a promise unfulfilled by previous Democratic leaders due to pharmaceutical industry influence. Kennedy claims there is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member, and the industry spends three times more on lobbying than any other. Kennedy states that Trump cannot be bought and is standing up to oligarchs, unlike other politicians. He notes that the US, with 4.2% of the world's population, accounts for 75% of pharmaceutical company revenues, spending $11.26 per capita on drugs compared to Britain's $240. Kennedy says Trump is asking European partners to increase their drug payments to fund innovation, suggesting a 20% increase would free up $10 trillion for innovation and improve global health.

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. Once approved for Medicare, it goes to Medicaid, and there's a push to recommend Ozempic for Americans as young as 6 for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the cost of Ozempic prescriptions for all of them would be $3 trillion a year. Novo Nordisk's value is based on projected Ozempic sales to Americans, yet the Danish government recommends diet and exercise instead. For half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. Congress is allegedly doing the bidding of Novo Nordisk instead of supporting American farmers and children because Novo Nordisk heavily funds medical research, the media, politicians, and medical schools.

We're paying too much for drugs compared to other countries, and existing laws make it hard to lower costs. The middlemen in the drug industry are profiting significantly without adding value. We're going to eliminate these middlemen to reduce drug prices to unprecedented levels. This topic dominated our discussions with executives and others involved.

Over a hundred members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its manufacturer. Once Medicare approves, Medicaid follows. There's a push to prescribe Ozempic for obesity in Americans as young as six, a condition largely preventable. With 74% of Americans obese, covering Ozempic prescriptions would cost $3 trillion annually. Novo Nordisk's value relies heavily on projected Ozempic sales in the US, yet Denmark, their home country, favors diet and exercise over the drug. For half the cost of Ozempic, we could provide regeneratively raised organic food to every American, three times a day, and gym memberships for every obese American. Why is Congress prioritizing this company over American well-being? I've dedicated my life to solving the childhood chronic disease crisis, and I see an opportunity for bipartisan change to improve American health, our economy, and our nation's spirit.

The people involved in drug companies, insurance companies, and the food industry work together, often holding stock in each other’s companies and serving on each other’s boards. The transcript describes this as a “criminal enterprise” and outlines one way it allegedly works. In the food industry’s meetings, food companies discuss adding ingredients and claim their chemists understand that each additive, in minute amounts, does not cause problems and has no long-term negative effects when consumed. The account then says that when three additives are combined, a new compound forms that leads to leg twitching or shaking. It may take three to five to seven years to develop because the effects impact nerves. The transcript describes the conversation as follows: the food companies would knowingly begin adding these ingredients because, years later, they expect hundreds of thousands or millions of people to develop symptoms and need treatment. They would propose labeling the condition—restless leg syndrome—when it emerges. The drug companies would then be prompted to have an approved drug ready by that time to generate major profits. It also claims that drug companies work toward these future “epidemics” by developing drugs in advance, contributing to the emergence of illnesses presented as widespread—such as psoriasis, diabetes, hypertension, restless leg syndrome, irritable bowel syndrome, and other conditions said to not have existed fifty years earlier. The transcript links these conditions to advertising campaigns where, if someone experiences twitching, they are told to take another drug. It describes the response as “take another drug.” Finally, insurance companies are said to become involved by figuring out how to profit. The transcript claims that through lobbyists, they work out deals so insurance and government-funded programs effectively pay for the drugs, citing Medicare and Medicaid in the United States. It says similar arrangements exist in other countries and concludes that these groups “make their money” through coordinated actions.

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world with tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. The speaker claims they don't care and have to do what's right.

I'm heading to Capitol Hill. They’re voting on the Shutdown Fairness Act today, but I figured something out. I think I understand why this shutdown is happening: why would the Democrats shut down the government, depriving federal workers and the military of pay and food, and depriving the military of their health care through Tricare? It doesn’t make sense. It has nothing to do with it being the far left or against Trump. It has to do with the insurance companies. The people responsible are insurance companies like United Healthcare, Aetna, Molina, Kaiser. They are getting paid every single month from the treasury, even as the government is shut down. So the insurance companies are getting mandatory payments while federal workers and the military get nothing. This isn’t about health care in the abstract; it’s about dark money from billion-dollar insurance companies. If they lose the ACA credits for next year, they won’t get any of that money. Tax credits are paid on behalf of the insured, and they go directly to the insurance companies. That’s why Democrats are fighting so hard on this: it has nothing to do with people’s premiums per se. It has to do with the insurance companies not getting billions and billions of dollars in January and next year. The shutdown, to me, finally makes sense: it’s about the billion-dollar insurance companies. And so much of the Democrats’ talking points—about premiums—miss the point. These are not market rates; they’re set by the insurance companies. They’re the ones deciding to keep people without health care. The government isn’t the main bottleneck; if anything, the government is helping the problem. The problem is the insurance companies. They set premiums, and their providers own hospitals and set obscene rates for procedures, profiting off the hospitals. This entire shutdown is about dark money from corporations like United Healthcare, Aetna, Kaiser, Molina, and their influence on our politicians. That’s why the government is shut down right now. The idea that Democrats might be acting because insurers threaten to withhold funding for reelection finally clicks. It’s all about health insurance companies, not about people trying to access health care. If the goal were to make access to care cheaper, they would force insurers to quit raising premiums and put a cap on those premiums every year.

A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker highlights the significant price difference, noting one person paid a small amount for the same shot in the UK. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world, according to the speaker, who questions the reason for this disparity.

I'm committed to making America healthier than other countries. Will you guarantee the same healthcare coverage that other major countries provide? Corruption isn't just in federal agencies; it's in Congress too. Many members here, including you, accept millions from the pharmaceutical industry to protect their interests. I ran for president and received millions in contributions, but none came from pharmaceutical executives or PACs. My support comes from workers, not corporate interests. You were the largest recipient of pharmaceutical donations in 2020. No, I received support from workers across the country, not from corporations. You still haven't answered the last question.

Politicians have long promised to address the discrepancy between drug prices in the U.S. and Europe. This issue was central to Bernie Sanders' presidential campaigns. However, these promises were never fulfilled because Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every member of Congress, the Senate, and the Supreme Court.

As a presidential candidate, the speaker plans to set drug prices based on fair market value, charging American consumers the average global price for drugs. For example, insulin prices would be impacted. If companies don't cooperate, the speaker intends to address drugs developed with federal funding. For any drug that benefited from taxpayer-funded research and development, and where companies fail to comply with pricing rules, the speaker will seize their patent. The speaker asserts this action is permissible and expresses the determination to execute it.

A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker stated that an individual in the UK paid a small amount for their shot, contrasting sharply with the $500 cost in the US. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world. The speaker questions the reason for this disparity.

Former President claims to have taken on big pharma with tough policies, but accuses President Biden of canceling them. He signed an executive order to ensure the US government pays the same price for pharmaceuticals as other countries. However, Biden rescinded this order, allegedly betraying patients and seniors. The US has been paying high prices for drugs while other countries negotiate lower prices. The former President promises to end this by signing an executive order that will only pay the best price offered to foreign nations. This will supposedly force big pharma to raise prices for other countries and reduce prices for American patients, resulting in significant savings.

Americans pay significantly more for prescription drugs than other countries, sometimes up to 10 times more. Pharmaceutical companies generate two-thirds of their profits in the U.S., effectively making Americans subsidize healthcare in other countries. The administration is introducing a "most favored nation" pricing model, ensuring the U.S. pays the lowest price available globally for drugs. For example, a breast cancer drug costing over $16,000 in the U.S. is a fraction of that price in Australia and Sweden. Similarly, an asthma drug costs almost $500 in the U.S. but less than $40 in the UK. The plan involves directing investigations into foreign nations that block drug products unless they accept low prices, and the U.S. will defend drug companies from unfair pricing demands. The administration aims to cut out middlemen and facilitate direct drug sales at the most favored nation price. If companies don't comply, the U.S. will use its trade powers and open the market to safe, legal drug imports.

Pharmaceutical companies spend three times more on lobbying than the next largest lobbyist. This issue was considered radioactive, but President Trump addressed it despite past contributions from pharmaceutical companies, which may have totaled $100,000,000. Unlike other politicians, Trump cannot be bought and is standing up for the American people. Despite claims from figures like Elizabeth Warren and Robert Reich that President Trump is on the side of the oligarchs, no president has been more willing to stand up to them than President Donald Trump. The speaker expressed pride in the President's courage and willingness to stand up for the American people.

Pharmaceutical companies spend three times more on lobbying than the next largest lobbyist. While many discussed the issue, nobody acted due to its controversial nature. President Trump, described as a man of his word, is willing to stand up to the oligarchs, unlike most politicians who can be bought. Despite allegedly receiving $100,000,000 from the pharmaceutical industry, Trump cannot be bought. The speaker praises President Trump for his courage and willingness to stand up for the American people.